Estudio de utilización de fármacos anticálcicos en 4 consultorios pertenecientes al “Policlínico Docente Universitario Santa Clara"
Cargando...
Archivos
Fecha
Autores
Rondón Romero, Marcos
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad Central "Marta Abreu" de Las Villas. Facultad de Química y Farmacia. Departamento de Licenciatura en Ciencias Farmacéuticas
Resumen
La Hipertensión arterial (HTA) es una enfermedad crónica no transmisible que constituye en la actualidad un problema de salud a nivel mundial. En el área de salud del Policlínico Docente Universitario Santa Clara existe un gran número de pacientes consumidores de anticálcicos en los cuales se han detectado una inadecuada prescripción y utilización de estos medicamentos. En el presente trabajo se realiza la evaluación de la prescripción del tratamiento de la Hipertensión arterial con estos medicamentos. Para ello, se realizó un estudio descriptivo, transversal, observacional y retrospectivo en una muestra de 219 pacientes hipertensos consumidores de anticálcicos en cuatro consultorios escogidos al azar. Se evaluó el conocimiento de los pacientes a través de entrevistas y se diseñó un proceso de intervención. Se determinó que el 57.07 % de los pacientes se encontraban en el rango de edad 65 años o más; y predominó el sexo femenino (57.99 %) y la raza blanca (54.33 %). El 47.03 % fue diagnosticado solamente con HTA y el 52.97 % con HTA asociada a otras patologías. El Amlodipino fue el anticálcico de mayor consumo (71.88 %). Los problemas relacionados con la medicación fueron: ilegibilidad de los certificados, la no clasificación de la HTA y dosificación e interacciones medicamentosas de los anticálcicos. En el estudio se definieron los principales problemas relacionados con la utilización de anticálcicos en una muestra del Policlínico Santa Clara. De manera general el paciente exhibe un bajo nivel de conocimiento, por lo que se propone una estrategia de intervención farmacéutica mediante el desarrollo de charlas educativas y presentación de materiales didácticos con el objetivo de educar al paciente.
Arterial Hypertension or high blood pressure (HBP) is a non-transmissible chronic disease that constitutes a worldwide health problem nowadays. In the health area of the " Santa Clara " University Teaching Polyclinic there is a large number of patient who are consumers of anti-calcic, in which an inadequate prescription and use of these medications have been detected. In the present work, it will be performed the evaluation of the treatment prescription of Arterial Hypertension with these medications. In order to do this; a descriptive, transversal, observational and retrospective study taking into account a sample of 219 hypertensive patients, which consume anti-calcic, was carried out in four consulting rooms chosen at random. The knowledge of the patients was evaluated through interviews, and a process of intervention was designed. It was determined that 57,07 % of patients were in the age range of 65 years or more; and female sex (57.99%) and white race (54.33%) predominated. The 47,03 % presented HBP and the 52,97 % presented HBP associated to other pathologies. The Amlodipine was the anti-calcic of higher consumption (71,88 %). The problems related with the medication were: illegibility of certificates, non-classification of HBP, dosage and drug-drug interactions. In the study, the main problems related with the utilization of anti-calcic in the Polyclinic Santa Clara's sample were defined. In general, the patients show a low knowledge level; therefore, a strategy of pharmaceutical intervention with the confection of resource materials with the objective of educating the patient and the development of educational talks.
Arterial Hypertension or high blood pressure (HBP) is a non-transmissible chronic disease that constitutes a worldwide health problem nowadays. In the health area of the " Santa Clara " University Teaching Polyclinic there is a large number of patient who are consumers of anti-calcic, in which an inadequate prescription and use of these medications have been detected. In the present work, it will be performed the evaluation of the treatment prescription of Arterial Hypertension with these medications. In order to do this; a descriptive, transversal, observational and retrospective study taking into account a sample of 219 hypertensive patients, which consume anti-calcic, was carried out in four consulting rooms chosen at random. The knowledge of the patients was evaluated through interviews, and a process of intervention was designed. It was determined that 57,07 % of patients were in the age range of 65 years or more; and female sex (57.99%) and white race (54.33%) predominated. The 47,03 % presented HBP and the 52,97 % presented HBP associated to other pathologies. The Amlodipine was the anti-calcic of higher consumption (71,88 %). The problems related with the medication were: illegibility of certificates, non-classification of HBP, dosage and drug-drug interactions. In the study, the main problems related with the utilization of anti-calcic in the Polyclinic Santa Clara's sample were defined. In general, the patients show a low knowledge level; therefore, a strategy of pharmaceutical intervention with the confection of resource materials with the objective of educating the patient and the development of educational talks.